Ladenburg Thalmann Financial Services Inc. lifted its stake in PowerShares Dynamic Biotech &Genome(ETF) (NYSEARCA:PBE) by 11.5% during the fourth quarter, Holdings Channel reports. The institutional investor owned 65,560 shares of the company’s stock after acquiring an additional 6,736 shares during the quarter. Ladenburg Thalmann Financial Services Inc.’s holdings in PowerShares Dynamic Biotech &Genome(ETF) were worth $3,092,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently modified their holdings of the company. Citadel Advisors LLC purchased a new stake in shares of PowerShares Dynamic Biotech &Genome(ETF) in the fourth quarter worth about $400,000. Virtu Financial LLC boosted its stake in shares of PowerShares Dynamic Biotech &Genome(ETF) by 357.6% in the fourth quarter. Virtu Financial LLC now owns 57,474 shares of the company’s stock worth $2,710,000 after buying an additional 44,913 shares during the last quarter. Finally, Wells Fargo & Company MN boosted its stake in shares of PowerShares Dynamic Biotech &Genome(ETF) by 1.4% in the fourth quarter. Wells Fargo & Company MN now owns 80,894 shares of the company’s stock worth $3,815,000 after buying an additional 1,096 shares during the last quarter.

How to Become a New Pot Stock Millionaire

Shares of PowerShares Dynamic Biotech &Genome(ETF) stock opened at $51.77 on Thursday. PowerShares Dynamic Biotech &Genom has a one year low of $40.77 and a one year high of $54.28. The company has a market capitalization of $265.00 and a PE ratio of 3.98.

TRADEMARK VIOLATION NOTICE: “PowerShares Dynamic Biotech &Genome(ETF) (PBE) Shares Bought by Ladenburg Thalmann Financial Services Inc.” was first reported by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another site, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this news story can be viewed at

PowerShares Dynamic Biotech &Genome(ETF) Company Profile

PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies.

Want to see what other hedge funds are holding PBE? Visit to get the latest 13F filings and insider trades for PowerShares Dynamic Biotech &Genome(ETF) (NYSEARCA:PBE).

Institutional Ownership by Quarter for PowerShares Dynamic Biotech &Genome(ETF) (NYSEARCA:PBE)

Receive News & Ratings for PowerShares Dynamic Biotech &Genome(ETF) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PowerShares Dynamic Biotech &Genome(ETF) and related companies with's FREE daily email newsletter.